KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 98 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $363,000 | – | 14,239 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 639,230 | $11,091,000 | 3.32% |
| Boxer Capital, LLC | 1,172,700 | $20,346,000 | 2.30% |
| Sofinnova Investments, Inc. | 1,845,400 | $32,018,000 | 2.04% |
| Hillhouse Capital Management | 5,736,527 | $99,529,000 | 1.70% |
| Cormorant Asset Management, LP | 831,000 | $13,842,000 | 1.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,226,890 | $21,287,000 | 0.75% |
| Foresite Capital Management IV, LLC | 94,477 | $1,639,000 | 0.56% |
| Vivo Capital, LLC | 186,073 | $3,228,000 | 0.42% |
| Baker Brothers Advisors | 3,000,000 | $52,050,000 | 0.39% |
| DC Investments Management, LLC | 30,817 | $535,000 | 0.34% |